Health Systems Urged to Rethink AI Hype

A BJC and WashU Medicine executive says medical AI has decades of research behind it and should not be treated as new.

Updated on Nov. 2, 2026 in Artificial Intelligence

Bold flat-color editorial illustration of a brass microscope lens and an empty glass petri dish on a steel laboratory bench in soft morning light.
Philip Payne, chief health AI officer at BJC HealthCare and WashU Medicine, urged health systems not to treat medical AI as new, citing research dating to the 1950s and 1960s. AI Illustration. Upload story photo >

Live Poll

Do you trust AI to be used safely in your own medical care?

Philip Payne, chief health AI officer at BJC HealthCare and WashU Medicine, warned health systems against treating medical AI as new during a panel at Newsweek's AI Health Summit in New York City. He said health systems risk overlooking AI research dating to the 1950s and 1960s.

Why it matters

Payne said the capability to deploy AI at scale has finally caught up with decades of research, making it important for health systems to build on that foundation. His comments suggest that organizations seeking results should plan for measurable outcomes rather than adopting tools without a clear pathway to evaluation.

Payne pointed to computerized identification of abnormal heart rhythms in 2018 as an example of AI already operating in clinics. Houston Methodist's continuous vital-sign monitoring has been used to identify problems earlier, though the extraction does not report measured outcome figures.

The players

Philip Payne

Chief health AI officer at BJC HealthCare and WashU Medicine, PhD-trained informatician with decades of experience in AI.

Rohit Chandra

Executive vice president and chief digital officer at Cleveland Clinic who described current AI as the most immature version health systems will see.

Bilal Muhsin

Executive vice president and president of the connected care segment at BD.

The details

Payne made the remarks on a panel alongside Rohit Chandra of Cleveland Clinic and Bilal Muhsin of BD. Payne said his program will not undertake an AI project without a clear pathway toward measuring outcomes, and he cited the joint Center for Health AI run by BJC and WashU Medicine as a means of bringing academic research into hospital settings.

Timeline

  1. 1950s and 1960s: Early AI research that health systems risk overlooking, according to Payne.

  2. 2018: Computerized heart rhythm identification cited by Payne as clinical AI.

  3. Late 2022: Most health systems began seriously considering organization-wide AI deployment.

The Tech Race

Payne's remarks place current medical AI within research dating to the 1950s and 1960s rather than treating it as a new frontier. Chandra's description of today's tools as the most immature version health systems will encounter suggests the field is at an early point in a longer development curve.

Patients at health systems deploying AI may see more continuous monitoring and earlier identification of problems, as at Houston Methodist. The extraction does not specify how these tools change individual care decisions or costs.

The takeaway

Health systems that treat AI as a proven, measurable tool rather than a novelty may be better positioned to show results. Readers should look for organizations that tie AI projects to clear outcome measurement.

Further reading

Explore more Artificial Intelligence coverage from St. Louis health systems.

Source note: This article includes information reported by Newsweek.

Live Poll

Do you trust AI to be used safely in your own medical care?